To explore different fusion genes in a single assay and to detect gene partners engaged in ALK (anaplastic lymphoma kinase) or ROS1 fusion, we evaluated two commercially available targeted RNA‐sequencing assays in a set of 37 tumor samples. This evidence concerns the gene ALK and neoplasm.